Skip to main content

Table 4 Characteristics of those responding "YES" to Q1 "wheezing", Q4 "coughing", Q5 "asthma", or Q7 "nasal" according to the ECRHS screening questionnaire (n = 184)

From: Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates

 

male

(n = 104)

female

(n = 80)

ALL

n = 184

p

Age in years, mean (SD)

34.0 (15.4)

31.3 (15.7)

32.8 (15.5)

0.247

Age band, n (%)

   

0.309

   • 19 yr or less

27 (26.0%)

18 (22.5%)

45 (24.5%)

 

   • 20 to 44 yr

47 (45.2%)

45 (56.3%)

92 (50.0%)

 

   • 45 yr or more

30 (28.8%)

17 (21.3%)

47 (25.5%)

 

ECRHS screening questionnaire symptoms within the last 12 months, n (%)

    

Wheezing/whistling

68 (65.4%)

57 (67.9%)

125 (66.5%)

0.758

   Wheezing with breathlessness

60 (57.7%)

51 (60.7%)

111 (59.0%)

0.916

   Wheezzing without a cold

59 (56.7%)

39 (46.4%)

98 (52.1%)

0.043*

Woken up with chest tightness

57 (54.8%)

44 (52.4%)

101 (53.7%)

0.770

Woken up by shortness of breath

59 (56.7%)

42 (50.0%)

101 (53.7%)

0.380

Woken up by an attack of coughing

70 (67.3%)

60 (71.4%)

130 (69.1%)

0.634

Attack of asthma

52 (50.0%)

47 (56.0%)

99 (52.7%)

0.464

Currently taking asthma medications

54 (51.9%)

41 (48.8%)

95 (50.5%)

0.769

Nasal allergies (including hay fever)

45 (43.3%)

40 (47.6%)

85 (45.2%)

0.559

  1. "*" Significant p-value